We view OHB’s share price weakness as unjustified given the further strengthening we expect in its order outlook. The company has secured a nearly € 1bn order for IRIS2, Sentinel is moving towards a final contract and we now see greater order potential from SATCOMBw 4. Q3 should show continued growth, with the main programme-driven earnings uplift still ahead. Upcoming contract awards should act as key share price catalysts.
LÄS MER
